Company intelligence / Profile preview

GOELAMS

Paris, France

Ownership: Private
Development stage: Other

Overview

Goelams is a specialized strategic consulting firm dedicated to global oncology drug development and medical strategy. Founded by Dr. Jean-Pierre Bizzari, a renowned expert in oncology who previously held senior leadership roles at Celgene and Sanofi-Aventis, the firm provides high-level advisory services to biotechnology and pharmaceutical companies. Goelams offers deep expertise in clinical development planning, regulatory strategy, and medical affairs, specifically tailored for oncology assets. The company assists clients in navigating the transition from preclinical research to clinical trials and optimizing the commercial potential of their cancer therapies.

Therapeutic areas: Oncology
Modalities: Small moleculeMonoclonal antibodyCell therapyBiologicAntibody-drug conjugate
Industry: Consulting

Beyond the preview

Go deeper on GOELAMS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GOELAMS.

Explore the full profile